---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-24-018348"
form_type: "8-K"
ticker: "BKYI"
cik: "0001019034"
company_name: "BIO KEY INTERNATIONAL INC"
filed_at: "2024-05-24T23:59:59+00:00"
generated_at: "2026-06-01T08:32:07.340855+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# BIO-key receives Nasdaq delisting notice for late 10-Q; restating prior periods

## Summary
- Received Nasdaq notice on May 22, 2024 for non-compliance with Listing Rule 5250(c)(1) due to late 10-Q filing for quarter ended March 31, 2024.
- Company remains delinquent on 2023 10-K; restating 2023 quarterly financial statements (Q1, Q2, Q3 2023).
- Must submit compliance plan by June 17, 2024; potential extension to October 14, 2024 if plan accepted.
- No immediate effect on listing or trading of common stock on Nasdaq Capital Market.
- Company intends to file Form 10-Q and Form 10-K as soon as practicable.

## SEC filing metadata
- accession: 0001437749-24-018348
- form_type: 8-K
- ticker: BKYI
- cik: 0001019034
- company_name: BIO KEY INTERNATIONAL INC
- filed_at: 2024-05-24T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1019034/000143774924018348/0001437749-24-018348-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1019034/000143774924018348/bkyi20240523_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-24-018348
- JSON: https://secwatch.observer/filing/0001437749-24-018348.json
- Plain text: https://secwatch.observer/filing/0001437749-24-018348.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.